A Multi-Concept Theme for Digital Agencies and Startups
Ministry of Health and Family Welfare has issued a directive to ban the manufacture, sale, and distribution of the fixed dose combination drug Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain, Antimony Potassium Tartrate + Dried Ferrous Sulphate, Benfotiamine + Silymarin + L-Ornithine L-aspartate + Sodium Selenite + Folic acid + Pyridoxine hydrochloride, Bismuth Ammonium Citrate + Papain, Cyproheptadine HCl + Thiamine HCl + Riboflavine + Pyridoxine HCl + Niacinamide, Cyproheptadine Hydrochloride + Tricholine Citrate + Thiamine Hydrochloride + Riboflavine + Pyridoxine Hydrochloride, Rabeprazole Sodium (As enteric coated tablet) + Clidinium Bromide + Dicyclomine HCl + Chlordiazepoxide, Fungal Diastase + Papain + Nux vomica Tincture + Cardamom Tincture + Casein Hydrolysed + Alcohol, Mefenamic Acid + Paracetamol Injection, Omeprazole Magnesium + Dicyclomine HCl, S-adenosyl methionine + Metadoxine + Ursodeoxycholicacid BP + L-Methylfolate Calcium eq. to L-Methylfolate + Choline bitartratee + Silymarin + L-ornithine L-aspartate + Inositol + Taurine, Silymarin + Thiamine Mononitrate + Riboflavin+ Pyridoxine HCl + Niacinamide + Calcium pantothenate + Vitamin B12, Silymarin + Pyridoxine HCl + Cyanocobalamin + Niacinamide + Folic Acid, Silymarin + Vitamin B6 + Vitamin B12 + Niacinamide + Folic acid + Tricholine Citrate for human use. By virtue of the circular, this action is based on recommendations from the Drugs Technical Advisory Board and the powers granted under section 26A of the Drugs and Cosmetics Act, 1940. The drug is deemed to have no therapeutic benefit and may pose risks to human health. Please refer to the attached document for more details.
Request a Demo
NSDL reiterated the circular issued by SEBI regarding IT Resilience Index for Market Infrastructure Institutions (MIIs) Through this circul
NSDL has issued circular regarding Updates for Implementation of Section 51A of UAPA, 1967 – Security Council 1267(1999) amends entri
BSE reiterated the circular issued by SEBI regarding Alignment of SEBI’s Cyber Incident Reporting Portal with FIRE format Through th
The International Financial Services Centres Authority has directed all Fund Management Entities registered under the Fund Management Regula
This notification introduces the Puducherry Occupational Safety, Health and Working Conditions Rules, 2026, which prescribe requirements rel
The Tamil Nadu Real Estate Regulatory Authority (TNRERA) has extended the validity of registration and corresponding completion timelines of
The Government of Himachal Pradesh has notified the Himachal Pradesh Narcotic Drugs and Psychotropic Substances (Second Amendment) Rules, 20
The Government of Himachal Pradesh has notified the Himachal Pradesh Narcotic Drugs and Psychotropic Substances (Amendment) Order, 2026, ame
Thank You for your interest in Complinity. Your CV has been forwarded to HR. In case your profile is shortlisted, HR shall contact you.
Thank You for your interest in Complinity. Your CV has been forwarded to HR.